Specialty pharmacy has become a critical part of today’s healthcare ecosystem.
It focuses on high-cost, complex therapies used to treat chronic, rare, or life-threatening conditions. These treatments often require special handling, strict payer approvals, limited distribution, and ongoing patient support.
Specialty pharmacy goes beyond dispensing a drug. It is about managing everything that needs to happen for that therapy to reach the patient and deliver results.
And that is exactly why it matters for pharma sales teams.
The Shift Sales Teams Can’t Ignore
The traditional model, where a physician prescribes and a pharmacy dispenses, doesn’t fully apply to specialty pharmacy.
Access to therapy depends on a network of stakeholders. Payers influence approval, specialty pharmacies control distribution, and providers manage both clinical and administrative complexity.
For sales teams, this changes the nature of every conversation.
Besides focusing on clinical value, teams need to understand how products move through the system, where barriers exist, and how different stakeholders make decisions.
Without that understanding, even strong messaging can fall short.
What Market Trends and Forces Are Affecting Specialty Pharmacy?
Several forces are rapidly reshaping how specialty therapies are accessed and delivered.
1. The specialty drug market is expanding quickly
Growth is being driven by new oncology and immunology therapies. A significant portion of new drug launches in the coming years will fall into specialty categories, especially in cancer and rare diseases.
2. Health systems are bringing specialty pharmacy in-house
More Integrated Delivery Networks (IDNs) are operating their own specialty pharmacies. This helps them manage costs, improve margins, streamline patient access, and maintain greater control over outcomes.
3. Payers are changing where care happens
To control costs, many health plans are implementing site-of-care restrictions. This shifts treatments, especially infusions, away from hospital settings to lower-cost options like physician offices, freestanding infusion centers, or even home-based care.
4. Manufacturers are tightening distribution
Limited Distribution Networks (LDNs) are becoming more common. By working with a smaller group of specialty pharmacies, manufacturers can better manage supply, monitor patient safety, and control how therapies are accessed.
Where the Gap Is Growing
While the market has evolved, training has not always kept pace.
Many sales teams still operate with a simplified view of access and distribution. This gap shows up in longer time to therapy, missed opportunities, and conversations that do not fully address stakeholder priorities.
Why This Matters Now
The urgency is real.
Specialty pharmacy is no longer a niche topic. It is central to how many therapies succeed. As pipelines continue to shift toward complex treatments, the ability to navigate this landscape is becoming a core capability.
Waiting to address this gap only makes it harder to close.
Bringing Clarity to Complexity
CMR Institute’s newly updated Specialty Pharmacy eBrief helps teams understand how specialty pharmacy works, including different bagging models, why reimbursement and coverage are complex, and the key market trends shaping the space.
It turns complexity into usable knowledge that teams can apply in real-world conversations.
Specialty pharmacy is now central to the commercial landscape.
For pharma sales teams, understanding it is essential to have relevant, effective conversations.
Contact CMR today to add this market-ready learning resource to your training program.
